Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | CXCR3 | P49682 | 4/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 4/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL289717 | 0.90 | OPRK1 (0.42) | HPGDP2RX7ALDH1A1MEN1KMT2A | |
| SCHEMBL5738047 | 0.88 | OPRK1 (0.41) | HPGDP2RX7ALDH1A1MEN1KMT2A | |
| Bromide SCHEMBL1478373 | 0.88 | OPRK1 (0.41) | HPGDP2RX7ALDH1A1MEN1KMT2A | |
| SCHEMBL2011475 | 0.88 | HPGD (0.39) | HPGDP2RX7ALDH1A1MEN1KMT2A | |
| SCHEMBL2018311 | 0.86 | MGAM (0.31) | HPGDCXCR3P2RX7ALDH1A1CYP17A1 | |
| SCHEMBL2015150 | 0.86 | MEN1 (0.40) | CXCR3P2RX7CYP17A1CYP19A1MEN1 | |
| SCHEMBL2015640 | 0.82 | ALDH1A1 (0.39) | HPGDP2RX7ALDH1A1CYP17A1CYP19A1 | |
| SCHEMBL3676522 | 0.80 | P2RX7 (0.33) | HPGDCXCR3P2RX7ALDH1A1SMN1; SMN2 | |
| SCHEMBL5078719 | 0.80 | — | — | |
| SCHEMBL1734830 | 0.79 | P2RX7 (0.39) | HPGDP2RX7ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2794548-B1 | A CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | LUCITE INT UK LTD (GB) | 2019-05-15 | — | — | EP | claimed |
| US-9382190-B2 | Continuous process for the carbonylation of ethylene | LUCITE INTERNATIONAL UK LIMITED (GB) | 2016-07-05 | — | — | US | claimed |
| US-20150099896-A1 | CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | LUCITE INTERNATIONAL UK LIMITED (GB) | 2015-04-09 | — | — | US | claimed |
| EP-1931471-B1 | CONTINUOUS CARBONYLATION PROCESS | LUCITE INT UK LTD (GB) | 2014-10-01 | — | — | EP | claimed |
| EP-2007703-B1 | METAL COMPLEXES FOR USE IN THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | LUCITE INT UK LTD (GB) | 2013-12-18 | — | — | EP | claimed |
| EP-1527038-B1 | PROCESS FOR THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUDS | LUCITE INT UK LTD (GB) | 2010-03-17 | — | — | EP | claimed |
| US-20090312561-A1 | METAL COMPLEXES | LUCITE INTERNATIONAL UK LIMITED (GB) | 2009-12-17 | — | — | US | claimed |
| US-20090216041-A1 | Catalyst System | LUCITE INTERNATIONAL UK LIMITED (GB) | 2009-08-27 | — | — | US | claimed |
| US-20080051475-A1 | Process for the Hydroformylation of Ethylenically Unsaturated Compounds | LUCITE INTERNATIONAL UK LIMITED (GB) | 2008-02-28 | — | — | US | claimed |
| EP-2243549-B1 | A CATALYST SYSTEM | LUCITE INT UK LTD (GB) | 2020-09-02 | — | — | EP | disclosed |
| EP-2794548-B1 | A CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | LUCITE INT UK LTD (GB) | 2019-05-15 | — | — | EP | disclosed |
| EP-2513031-B1 | A CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | LUCITE INT UK LTD (GB) | 2018-08-22 | — | — | EP | disclosed |
| US-9802185-B2 | Catalyst system | LUCITE INTERNATIONAL UK LIMITED (GB) | 2017-10-31 | — | — | US | disclosed |
| US-9382190-B2 | Continuous process for the carbonylation of ethylene | LUCITE INTERNATIONAL UK LIMITED (GB) | 2016-07-05 | — | — | US | disclosed |
| US-20090312561-A1 | METAL COMPLEXES | LUCITE INTERNATIONAL UK LIMITED (GB) | 2009-12-17 | — | — | US | disclosed |
| US-20090216041-A1 | Catalyst System | LUCITE INTERNATIONAL UK LIMITED (GB) | 2009-08-27 | — | — | US | disclosed |
| US-7371705-B2 | Phospha-adamantane(s) catalytic system | LUCITE INTERNATIONAL UK LIMITED (GB) | 2008-05-13 | — | — | US | disclosed |
| US-20080051475-A1 | Process for the Hydroformylation of Ethylenically Unsaturated Compounds | LUCITE INTERNATIONAL UK LIMITED (GB) | 2008-02-28 | — | — | US | disclosed |
| US-20070282124-A1 | Catalyst System | LUCENT INTERNATIONAL UK LIMITED (GB) | 2007-12-06 | — | — | US | disclosed |
| US-20060106259-A1 | Phospha-adamantane(s) catalytic system | LUCITE INTERNATIONAL UK LIMITED (GB) | 2006-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060106259-A1 | Phospha-adamantane(s) catalytic system | ADORA2A, ADORA3, ADGRE5 | HPGD 1939/4885CXCR3 2007/4885P2RX7 1449/4885 |
| US-20150099896-A1 | CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | SCD, ELOVL6, ALK | HPGD 3290/4885CXCR3 3659/4885P2RX7 4835/4885 |
| US-20090216041-A1 | Catalyst System | CBS, SMS, POF1B | HPGD 2082/4885CXCR3 4492/4885P2RX7 4126/4885 |
| US-20080051475-A1 | Process for the Hydroformylation of Ethylenically Unsaturated Compounds | ETV6, DHPS, ELOVL6 | HPGD 129/4885CXCR3 1873/4885P2RX7 3871/4885 |
| US-20070282124-A1 | Catalyst System | SMS, COASY, ABCB7 | HPGD 2397/4885CXCR3 2835/4885P2RX7 1265/4885 |
| US-20090312561-A1 | METAL COMPLEXES | MLX, PICALM, AP2M1 | HPGD 3433/4885CXCR3 393/4885P2RX7 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.